These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 14530472

  • 1. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
    Yokoyama I, Inoue Y, Moritan T, Ohtomo K, Nagai R.
    J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
    [Abstract] [Full Text] [Related]

  • 2. Measurement of skeletal muscle glucose utilization by dynamic 18F-FDG PET without arterial blood sampling.
    Yokoyama I, Inoue Y, Moritan T, Ohtomo K, Nagai R.
    Nucl Med Commun; 2005 Jan; 26(1):31-7. PubMed ID: 15604945
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
    Trägårdh M, Møller N, Sørensen M.
    J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
    [Abstract] [Full Text] [Related]

  • 7. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF, Oyen WJ.
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [Abstract] [Full Text] [Related]

  • 8. Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
    Kelley DE, Williams KV, Price JC, Goodpaster B.
    J Nucl Med; 1999 Nov; 40(11):1798-804. PubMed ID: 10565773
    [Abstract] [Full Text] [Related]

  • 9. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis.
    Wu H, Dimitrakopoulou-Strauss A, Heichel TO, Lehner B, Bernd L, Ewerbeck V, Burger C, Strauss LG.
    Eur J Nucl Med; 2001 Jun; 28(6):704-10. PubMed ID: 11440030
    [Abstract] [Full Text] [Related]

  • 10. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS.
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia.
    Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Aoyagi T, Sugiura S, Yamada N, Ohtomo K, Sasaki Y, Omata M, Yazaki Y.
    J Nucl Med; 1999 Jul; 40(7):1116-21. PubMed ID: 10405129
    [Abstract] [Full Text] [Related]

  • 13. Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans.
    Peltoniemi P, Lönnroth P, Laine H, Oikonen V, Tolvanen T, Grönroos T, Strindberg L, Knuuti J, Nuutila P.
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1122-30. PubMed ID: 11052968
    [Abstract] [Full Text] [Related]

  • 14. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
    Toyama H, Ichise M, Liow JS, Modell KJ, Vines DC, Esaki T, Cook M, Seidel J, Sokoloff L, Green MV, Innis RB.
    J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
    Herrero P, Sharp TL, Dence C, Haraden BM, Gropler RJ.
    J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
    [Abstract] [Full Text] [Related]

  • 16. Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.
    Strauss LG, Dimitrakopoulou-Strauss A, Haberkorn U.
    J Nucl Med; 2003 Dec; 44(12):1933-9. PubMed ID: 14660719
    [Abstract] [Full Text] [Related]

  • 17. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis.
    Virtanen KA, Peltoniemi P, Marjamäki P, Asola M, Strindberg L, Parkkola R, Huupponen R, Knuuti J, Lönnroth P, Nuutila P.
    Diabetologia; 2001 Dec; 44(12):2171-9. PubMed ID: 11793018
    [Abstract] [Full Text] [Related]

  • 18. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
    Paquet N, Albert A, Foidart J, Hustinx R.
    J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
    [Abstract] [Full Text] [Related]

  • 19. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C, Osman M, Pannu HK, Wahl RL.
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [Abstract] [Full Text] [Related]

  • 20. Exercise training favors increased insulin-stimulated glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized study using FDG PET imaging.
    Reichkendler MH, Auerbach P, Rosenkilde M, Christensen AN, Holm S, Petersen MB, Lagerberg A, Larsson HB, Rostrup E, Mosbech TH, Sjödin A, Kjaer A, Ploug T, Hoejgaard L, Stallknecht B.
    Am J Physiol Endocrinol Metab; 2013 Aug 15; 305(4):E496-506. PubMed ID: 23800880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.